JP2000005322A - Medical liquid injection port - Google Patents

Medical liquid injection port

Info

Publication number
JP2000005322A
JP2000005322A JP10170823A JP17082398A JP2000005322A JP 2000005322 A JP2000005322 A JP 2000005322A JP 10170823 A JP10170823 A JP 10170823A JP 17082398 A JP17082398 A JP 17082398A JP 2000005322 A JP2000005322 A JP 2000005322A
Authority
JP
Japan
Prior art keywords
port
injection port
internal space
elastic body
filament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10170823A
Other languages
Japanese (ja)
Inventor
Yukihiko Sakaguchi
幸彦 坂口
Seiki Arikawa
清貴 有川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Bakelite Co Ltd
Original Assignee
Sumitomo Bakelite Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Bakelite Co Ltd filed Critical Sumitomo Bakelite Co Ltd
Priority to JP10170823A priority Critical patent/JP2000005322A/en
Publication of JP2000005322A publication Critical patent/JP2000005322A/en
Pending legal-status Critical Current

Links

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a medicinal liquid injection port which enables the insertion of a filament in addition to ordinary medicinal liquid injection and is adaptable to various kinds of applications by exclusively installing the medicinal liquid injection port and filament insertion port respectively communicating with an internal space storing a medicinal liquid and sealing the both port with respective elastic bodies. SOLUTION: The medicinal liquid injection port 1 is embedded between the patient's subcutaneous fat and the fascia layer, is indwelt in the blood vessel and is connected to a catheter 11. Ordinary medicinal liquid administration is executed by pricking an elastic body 3 of the medicinal liquid injection port 2 with a needle of injection and injecting the medicinal liquid into the blood vessel from the main body of the port 1 via the catheter 11 connected to a connector 6. On the other hand, and the time treatment such as embolectomy, angiography or repair of the catheter 11, a doctor makes palpation from above the skin and confirms the filament insertion port 7, then pricks the elastic body 8 with a needle with a canula and removes the needle to indwell only the canula 13. The filament 14, such as a guide wire, is thereafter inserted into the canula 13 and is inserted down to the desired blood vessel in perspective.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、進行癌患者の化学
療法における抗癌剤の動脈内注入、栄養補給のための静
脈注入、鎮痛のための髄硬膜等への鎮痛剤の投与、糖尿
病患者へのインシュリン投与等の如く、患者の体内の特
定箇所に長期間継続して、定期的に薬液を注入するため
の、皮下埋め込み可能な薬液注入システムに関するもの
である。
The present invention relates to an arterial infusion of an anticancer agent in chemotherapy for an advanced cancer patient, intravenous infusion for nutritional supplementation, administration of an analgesic agent to the meninges for analgesia, and to a diabetic patient. The present invention relates to a medicinal solution injection system that can be implanted subcutaneously for continuously and periodically injecting a medicinal solution into a specific part of a patient's body for a long period of time, such as insulin administration.

【0002】[0002]

【従来の技術】切除不能な悪性腫瘍に対しては、抗癌剤
投与による化学療法が行われているが、全身投与法では
副作用を生じるため、選択的投与法としてカテーテル先
端を腫瘍局所へ通じる動脈上流に留置し、端末を抗癌剤
注入口として体外に露出させたままにするか、或は抗癌
剤投与の都度カテーテルを再挿入していた。(動注化学
療法)また、高カロリー輸液の持続注入の場合にも、カ
テーテル先端を中心静脈内に留置し、端末を輸液注入口
として体外に露出させていた。(IVH)このためカテ
ーテルを挿入した皮膚創部からの感染の防止は懸案課題
であるが、一方皮膚創部を常に清潔に保つことは実生活
上は極めて困難であり、かつ患者の自由な行動や入浴等
にも制約があり、社会復帰に大きな妨げとなっていた。
2. Description of the Related Art Chemotherapy is administered to unresectable malignant tumors by administering anticancer drugs. However, systemic administration causes side effects. And the terminal was left exposed outside the body as an anticancer drug injection port, or the catheter was reinserted each time the anticancer drug was administered. (Arterial infusion chemotherapy) Also, in the case of continuous infusion of high-calorie infusion, the catheter tip was placed in the central vein and the terminal was exposed outside the body as an infusion inlet. (IVH) For this reason, prevention of infection from the skin wound where a catheter is inserted is a matter of concern, but keeping the skin wound clean at all times is extremely difficult in real life, and the patient's free behavior and bathing There were also restrictions on this, and this was a major obstacle to rehabilitation.

【0003】このような問題の解決手段として、体内に
長期間留置した状態で使用可能な皮下埋込型のカテーテ
ル組立体が開発されている。このカテーテル組立体とは
薬液を貯留するための内部空間と、頂部にこの内部空間
に連通する円柱形の弾性体を圧縮装着した薬液注入口、
およびコネクターが付設された薬液流出路を有するポー
ト本体と、薬液注入用のルーメンが形成されたカテーテ
ルとを、前記流出路にルーメンが連通するように前記コ
ネクターにカテーテルを接続したものである。本皮下埋
込型カテーテル組立体は、カテーテルを目的の血管内等
まで挿入し、薬液注入ポートを皮下組織に固定した状態
で留置される。そして、薬液を注入する際は、皮膚の上
から触診により薬液注入ポートの薬液注入口を確認し、
薬液注入口の弾性体を注射針にて穿刺することにより薬
液をポート本体内に送り込み、カテーテルを介して目的
の血管内等へ注入する。
As a means for solving such a problem, a subcutaneously implantable catheter assembly which can be used while being left in the body for a long time has been developed. This catheter assembly has an internal space for storing a drug solution, and a drug solution inlet compression-mounted with a columnar elastic body communicating with the internal space at the top,
And a port main body having a drug solution outflow passage provided with a connector, and a catheter formed with a lumen for injecting a drug solution, wherein a catheter is connected to the connector such that the lumen communicates with the outflow passage. The subcutaneous implantable catheter assembly is placed in a state where the catheter is inserted into a target blood vessel or the like and the drug solution injection port is fixed to the subcutaneous tissue. And when injecting the drug solution, check the drug solution inlet of the drug solution injection port by palpation from above the skin,
The drug solution is sent into the port body by puncturing the elastic body of the drug solution inlet with an injection needle, and injected into a target blood vessel or the like via a catheter.

【0004】ここまでが従来からの薬液注入ポートで実
施されてきた使用方法であるが、更なる用途として腫瘍
の治癒具合により血流の改変を実施することにより、更
に効果的で副作用の少ない薬液投与が実施可能となる。
この場合留置カテーテルの先端よりも抹消側の血流改変
のために造影剤や塞栓物質等を注入する操作が必要とな
るがこれら凝固性の高い薬剤を薬液注入ポート内に注入
するとシステム内の詰まりを生じ使用不能となるため薬
液注入ポート以外の別ルートよりマイクロカテーテル等
を挿入して実施されることになる。しかしながらより迅
速に目的である現留置カテーテル先端へマイクロカテー
テル等を挿入するためには、薬液注入ポートおよび現留
置カテーテル内のルートを使用することが迅速、確実で
あることは明らかであるが、従来の薬液注入ポートは薬
液注入口とコネクター部がほぼ垂直をなしているためマ
イクロカテーテル等の挿入していくことはできなかっ
た。
[0004] Up to this point, the conventional method has been used at the liquid injection port, but as a further application, the blood flow is modified according to the healing condition of the tumor, so that the liquid is more effective and has less side effects. Administration becomes feasible.
In this case, it is necessary to inject a contrast agent or an embolic substance to modify the blood flow on the peripheral side of the indwelling catheter, but if these highly coagulable drugs are injected into the drug solution injection port, the system may become clogged. Therefore, the micro catheter is inserted from another route other than the drug solution injection port. However, in order to insert a microcatheter or the like into the tip of the indwelling catheter more quickly, it is clear that it is quick and reliable to use the drug solution injection port and the route in the indwelling catheter. In the liquid injection port, the liquid injection port was almost perpendicular to the connector, so that a microcatheter or the like could not be inserted.

【0005】これを解決すべくマイクロカテーテル等の
フィラメントを挿入するための薬液注入ポートとして特
開昭64−70076号公報や特表平8−501008
号公報に示すものが考案されているが従来の薬液注入の
実施に対しては内部空間が長く縦長のため、注射針の針
先が底面に当たった感触が得られず誤穿刺の可能性があ
った。特に抗癌剤注入時における誤穿刺は皮膚壊死にも
つながる重篤な合併症になりうるため、術者が慣れてい
る従来同様の頂部穿刺による注入操作により行えること
が非常に大切であった。また頻繁に行われる薬液注入に
よる注射針の穿刺に対して、頻度は稀であるがフィラメ
ント挿入用の太径のカニューラ針の穿刺を兼用にして弾
性体に実施することになるため弾性体の損傷が著しく耐
久性に問題があった。
In order to solve this problem, a liquid injection port for inserting a filament such as a microcatheter has been disclosed in Japanese Patent Application Laid-Open No. 64-77076 and Japanese Patent Application Laid-Open No. 8-501008.
However, since the internal space is long and vertically long for the conventional liquid injection, the feel of the needle tip of the injection needle hitting the bottom surface is not obtained, and there is a possibility of puncture by mistake. there were. In particular, erroneous puncture at the time of injection of an anticancer drug can be a serious complication leading to skin necrosis. Therefore, it is very important that the puncture can be performed by an injection operation using a top puncture in the same manner as a conventional technique, which is used by operators. In addition, the puncture of the injection needle due to the frequent injection of the drug solution is rarely performed, but the puncture of the large-diameter cannula needle for inserting the filament is also performed on the elastic body. Had a remarkable durability problem.

【0006】[0006]

【発明が解決しようとする課題】本発明は、従来のこの
ような問題点を解消することを目的とするもので、薬液
注入口とフィラメント挿入口とをそれぞれ専用に設置し
てあるため従来と同様に薬液注入が実施できるのみなら
ず、塞栓術、血管造影更に留置カテーテルの修正等種々
の用途に合わせて実施できるより安全な薬液注入ポート
を提供するものである。
SUMMARY OF THE INVENTION An object of the present invention is to solve the above-mentioned conventional problems. Since a chemical solution inlet and a filament insertion port are provided exclusively, respectively, the present invention is different from the prior art. Similarly, the present invention provides a safer liquid injection port that can be used not only for performing liquid injection but also for various uses such as embolization, angiography, and modification of an indwelling catheter.

【0007】[0007]

【課題を解決するための手段】即ち本発明は、薬液を貯
留するための内部空間と、この内部空間に連通する薬液
注入口と、この薬液注入口を封止する弾性体と、前記内
部空間に連通する薬液流出路とを有し、該薬液流出路先
にコネクターを備え、更に該コネクターと対向するポー
ト後端壁に前記内部空間に連通するフィラメント挿入口
と、このフィラメント挿入口を封止する弾性体が設けら
れている薬液注入ポートであって前記薬液流出路は内部
空間からコネクター内腔まで連続的に内径が縮小してい
ることを特徴とする薬液注入ポートである。
That is, the present invention provides an internal space for storing a chemical solution, a chemical liquid inlet communicating with the internal space, an elastic body for sealing the chemical liquid inlet, and the internal space. And a connector at the tip of the drug solution outflow path, and a filament insertion port communicating with the internal space at a port rear end wall facing the connector, and sealing the filament insertion port. A chemical solution injection port provided with an elastic body having an inner diameter that continuously decreases from the internal space to the inner cavity of the connector.

【0008】[0008]

【発明の実施の形態】以下、図面をもとに本発明につい
て詳細に説明する。図1は本発明による薬液注入ポート
の一実施例を示す図で、図2は本発明による薬液注入ポ
ートの一実施例を示す内部空間、薬液流出路およびコネ
クターの上面図である。図1の如く本発明の薬液注入ポ
ート(1)は薬液を貯留するための内部空間(4)を有
し、この上部に弾性体(3)を装着した薬液注入口
(2)を有し、更に一半径方向に薬液流出路(5)が設
けてありその先にカテーテルを接続するためのコネクタ
ー(6)が付設されており、更に薬液流出路(5)の1
80度反対側に弾性体(8)を装着したフィラメント挿
入口(7)が設けられている。
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail with reference to the drawings. FIG. 1 is a view showing one embodiment of a chemical injection port according to the present invention, and FIG. 2 is a top view of an internal space, a chemical outflow passage, and a connector showing one embodiment of the chemical injection port according to the present invention. As shown in FIG. 1, the drug solution injection port (1) of the present invention has an internal space (4) for storing a drug solution, and has a drug solution inlet (2) having an elastic body (3) mounted thereon, Further, a drug solution outflow channel (5) is provided in one radial direction, and a connector (6) for connecting a catheter is provided at the tip of the drug solution outflow channel (5).
A filament insertion port (7) provided with an elastic body (8) is provided on the opposite side by 80 degrees.

【0009】薬液注入口(2)は従来同様ポート頂部に
設置されており、望ましくはフィラメント挿入口(7)
との判別を容易にするため反対向きにポート底面に対す
る角度αが60〜90度の傾斜を持たせることが望まし
く60度以下では注射針先端がフィラメント挿入口
(7)封止の弾性体(8)を傷付ける恐れがあるため望
ましくない。そしてフィラメント挿入口(7)は薬液注
入口(2)と反対向きにポート底面に対する角度βが0
〜30度の傾斜を持たせることが望ましく、30度以上
ではポート底面と平行に位置する薬液流出路(5)およ
びコネクター(6)とすなわち30度以上をなしフィラ
メントの挿入が困難となり望ましくない。薬液注入口
(2)の大きさについては従来同様盲目的に注射針を穿
刺するために広いことが望ましいが耐圧との兼ね合いで
10〜13mm径程度が妥当であり、封止される弾性体
(3)の厚みは5±2mm程度であることが望ましい。こ
れに対しフィラメント挿入口(7)については大きさは
後の薬液流出路(5)およびコネクター(6)へのフィ
ラメント誘導のため広すぎず5〜8mm径程度で、フィラ
メント挿入用の太径のカニューラ付針を穿刺するため弾
性体(8)は厚めに7±2mm程度の厚みが望ましい。
The chemical liquid inlet (2) is provided at the top of the port as in the prior art, and is preferably a filament insertion port (7).
It is desirable that the angle α with respect to the port bottom face be in the opposite direction at an angle of 60 to 90 degrees in order to facilitate the determination of the elastic needle (8). ) Is not desirable because of the possibility of damaging it. Then, the angle β with respect to the port bottom face is 0 in the direction opposite to the liquid inlet 2 in the filament insertion port 7.
It is desirable to have an inclination of up to 30 degrees, and if it is more than 30 degrees, it will not be more than 30 degrees with the drug solution outflow path (5) and the connector (6) located parallel to the bottom of the port, and it will be difficult to insert the filament. The size of the drug solution inlet (2) is desirably wide to blindly puncture the injection needle as in the past, but it is appropriate to have a diameter of about 10 to 13 mm in view of the pressure resistance, and the sealed elastic body ( The thickness of 3) is desirably about 5 ± 2 mm. On the other hand, the size of the filament insertion port (7) is about 5 to 8 mm without being too wide for guiding the filament to the drug solution outflow path (5) and the connector (6) later. In order to puncture a needle with a cannula, it is desirable that the elastic body (8) be thicker, about 7 ± 2 mm.

【0010】薬液流出路(5)は前述のごとくフィラメ
ントをコネクター(6)へ導くため連続的に内径が縮小
しており、図2に示すように内部空間(4)の外径から
コネクター(6)の後端内径まで連続的に縮小している
ことが薬液の滞留を防ぐことも含めもっとも望ましい。
内部空間(4)は薬液の滞留が起きぬようデッドスペー
スのない形状が要求されるため、フィラメント挿入口
(7)封止の弾性体(8)の先端面(10)の位置が内
部空間(4)の側壁面位置に一致していることが望まし
い。また、薬液注入口(2)およびフィラメント挿入口
(7)の外周には触診による判別を容易にするための突
起(9)を設けることもより望ましい。
As described above, the inside diameter of the chemical solution outflow path (5) is continuously reduced in order to guide the filament to the connector (6), and as shown in FIG. ) It is most desirable that the diameter is continuously reduced to the inner diameter of the rear end, including prevention of stagnation of the chemical solution.
Since the inner space (4) is required to have a shape without dead space so that the liquid medicine does not stay, the position of the distal end face (10) of the elastic body (8) sealed with the filament insertion opening (7) is adjusted to the inner space ( It is desirable that the position coincides with the side wall surface position of 4). Further, it is more desirable to provide a projection (9) on the outer periphery of the chemical solution inlet (2) and the filament insertion port (7) for facilitating discrimination by palpation.

【0011】次に各々の材質について述べると薬液注入
ポート(1)の本体材質としては、生体内に長期留置す
ることより生体適合性に優れていることが必要で、しか
も熱変形温度が体温の約2倍である70℃以上であるこ
とが望ましく例えばポリウレタン、ポリエーテルスルフ
ォン、シリコーンゴム等の樹脂やステンレス、チタニウ
ム等の金属、或いはこれらの組合せでも何ら構わない。
特に穿刺針の接触する内部空間底面に前記金属を用いる
ことは望ましい実施例の一つである。また、弾性体
(3)、および(8)の材質としては、自己封止性を有
する弾性状物質であり、例えばシリコーン、イソプレー
ン、ラテックス等のゴムが考えられるが軟質の塩化ビニ
ルやポリウレタン樹脂でも針刺し耐久性および生体適合
性に優れていれば使用可能である。更にコネクター
(6)の材質としては、強度的にステンレスやチタニウ
ム等の金属が望ましいが限定されるものではない。薬液
注入ポート(1)は以上の構成部品をインサート成形や
接着及び溶着等により組み立てられる。
Next, each material will be described. The main body material of the liquid injection port (1) needs to be superior in biocompatibility to a long-term indwelling in a living body, and the heat deformation temperature is lower than the body temperature. Desirably, the temperature is 70 ° C. or more, which is about twice as high, and for example, a resin such as polyurethane, polyethersulfone, or silicone rubber, a metal such as stainless steel or titanium, or a combination thereof may be used.
In particular, the use of the metal on the bottom surface of the internal space where the puncture needle contacts is one of the preferred embodiments. The material of the elastic bodies (3) and (8) is an elastic substance having self-sealing properties, for example, rubber such as silicone, isoprene, latex, etc., but soft vinyl chloride or polyurethane resin. However, it can be used if it has excellent needle sticking durability and biocompatibility. Further, the material of the connector (6) is preferably a metal such as stainless steel or titanium from the viewpoint of strength, but is not limited. The chemical injection port (1) is assembled by insert molding, bonding and welding of the above components.

【0012】次に使用方法について図3を用いて説明す
る。薬液注入ポート(1)は皮下脂肪層と筋膜層の間に
埋め込まれ血管内に留置されたカテーテルと接続され
る。通常の薬液投与は図3aに示すように皮膚の上から
触診により薬液注入口(2)を確認し、薬液注入口
(2)の弾性体(3)を注射針(12)にて穿刺するこ
とにより薬液をポート(1)本体内に送り込み、カテー
テル(11)を介して目的の血管内等へ薬液を注入す
る。次いで塞栓術、血管造影、またカテーテルの逸脱修
正や折れ曲がり等による詰まり解除、等の処置を薬液注
入ポート(1)およびカテーテル(11)を介してマイ
クロカテーテル等を挿入することにより実施するための
方法を述べると、図3bに示すように薬液投与同様、皮
膚の上から触診によりフィラメント挿入口(7)を確認
し、弾性体(8)をカニューラ(13)付穿刺針にて穿
刺し、穿刺針を抜去しカニューラ(13)のみを留置す
る。処置に使用するガイドワイヤーまたはマイクロカテ
ーテル等のフィラメント(14)をカニューラ(13)
内に挿入し透視下に目的の血管まで挿入し、目的の処置
を実施する。なお、この際使用されるカニューラ付穿刺
針は先端がペンシルポイント等の針穴のないものを使用
することが弾性体(8)の耐久性を向上させることがで
きるため望ましい。
Next, the method of use will be described with reference to FIG. The drug solution injection port (1) is connected to a catheter embedded between the subcutaneous fat layer and the fascia layer and placed in the blood vessel. In normal drug administration, as shown in FIG. 3a, the drug solution inlet (2) is confirmed by palpation from above the skin, and the elastic body (3) of the drug solution inlet (2) is punctured with the injection needle (12). To send the drug solution into the port (1) body, and inject the drug solution into a target blood vessel or the like via the catheter (11). Then, a method for performing a procedure such as embolization, angiography, and release of clogging due to deviation correction or bending of the catheter, etc. by inserting a microcatheter or the like through the drug solution injection port (1) and the catheter (11). 3b, the filament insertion port (7) is confirmed by palpation from above the skin, and the elastic body (8) is punctured with a puncture needle with a cannula (13), as in the case of administration of the drug solution as shown in FIG. 3b. And leave only the cannula (13). A filament (14) such as a guide wire or a microcatheter used for the treatment is cannulated (13).
To the target blood vessel under fluoroscopy, and perform the target treatment. In this case, it is preferable to use a cannula-equipped puncture needle having a tip with no needle hole such as a pencil point because the durability of the elastic body (8) can be improved.

【0013】[0013]

【発明の効果】以上に述べた如く、本発明による薬液注
入ポートは、薬液注入口とフィラメント挿入口をそれぞ
れ専用に設置してあるため従来と同様に薬液注入操作が
行え、しかもフィラメントが挿入可能なため塞栓術、血
管造影、更に留置カテーテルの修正等それぞれの用途に
合わせて実施できる用具として極めて有用である。
As described above, in the chemical liquid injection port according to the present invention, the chemical liquid injection port and the filament insertion port are provided respectively for exclusive use, so that the chemical liquid injection operation can be performed as in the conventional case, and the filament can be inserted. Therefore, it is extremely useful as a tool that can be performed according to each application such as embolization, angiography, and modification of an indwelling catheter.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の一実施例となる薬液注入ポートを示す
側断面図である。
FIG. 1 is a side sectional view showing a chemical solution injection port according to one embodiment of the present invention.

【図2】本発明の一実施例となる薬液注入ポートの内部
空間、薬液流出路およびコネクターを示す上面図であ
る。
FIG. 2 is a top view showing an internal space of a chemical solution injection port, a chemical solution outflow path, and a connector according to one embodiment of the present invention.

【図3】本発明の一実施例となる薬液注入ポートの使用
方法を示すa通常薬液投与時、bフィラメント挿入時の
側断面図である。
FIG. 3 is a side sectional view showing a method of using a drug solution injection port according to an embodiment of the present invention, in which a normal drug solution is administered and b filament is inserted.

【符号の説明】[Explanation of symbols]

1 薬液注入ポート 8 弾性体 2 薬液注入口 9 突起 3 弾性体 10 弾性体先端面 4 内部空間 11 カテーテル 5 薬液流出路 12 薬液注入用注射針 6 コネクター 13 カニューラ 7 フィラメント挿入口 14 フィラメント DESCRIPTION OF SYMBOLS 1 Chemical liquid injection port 8 Elastic body 2 Chemical liquid inlet 9 Protrusion 3 Elastic body 10 Elastic body tip surface 4 Internal space 11 Catheter 5 Chemical liquid outflow path 12 Chemical liquid injection needle 6 Connector 13 Cannula 7 Filament insertion port 14 Filament

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 薬液を貯留するための内部空間と、この
内部空間に連通する薬液注入口と、この薬液注入口を封
止する弾性体と、前記内部空間に連通する薬液流出路と
を有し、該薬液流出路先にコネクターを備え、更に該コ
ネクターと対向するポート後端壁に前記内部空間に連通
するフィラメント挿入口と、このフィラメント挿入口を
封止する弾性体が設けられている薬液注入ポートであっ
て前記薬液流出路は内部空間からコネクター内腔まで連
続的に内径が縮小していることを特徴とする薬液注入ポ
ート。
1. An internal space for storing a chemical solution, a chemical liquid inlet communicating with the internal space, an elastic body sealing the chemical liquid inlet, and a chemical liquid outflow passage communicating with the internal space. A chemical solution provided with a connector at the tip of the chemical solution outflow path, and further provided with a filament insertion port communicating with the internal space at a rear end wall of the port facing the connector, and an elastic body sealing the filament insertion port; An injection port, wherein the chemical solution outflow path has an inner diameter continuously reduced from an internal space to a connector bore.
【請求項2】 内部空間内に薬液の滞留するデッドスペ
ースが無いようフィラメント挿入口を封止する弾性体の
先端面が内部空間側壁面と同位置をなしている請求項1
記載の薬液注入ポート。
2. A front end surface of an elastic body for sealing a filament insertion opening is formed at the same position as a side wall surface of the internal space so that there is no dead space in which a chemical solution stays in the internal space.
The described drug solution injection port.
【請求項3】 薬液流出路平面断面形状が、コネクター
内腔幅と内部空間を形成する外周円との接線とで囲まれ
ている請求項1又は2記載の薬液注入ポート。
3. The chemical liquid injection port according to claim 1, wherein the chemical liquid outflow passage has a planar cross-sectional shape surrounded by a tangent to the width of the inner cavity of the connector and an outer peripheral circle forming the internal space.
【請求項4】 ポート底面に対し薬液注入口が60〜9
0度の角度をなし、該薬液注入口と反対向きにポート底
面に対しフィラメント挿入口が0〜30度の角度をなし
ている請求項1〜3記載のいずれかの薬液注入ポート。
4. A chemical solution inlet for a bottom of a port is 60-9.
4. The drug solution injection port according to claim 1, wherein the filament insertion port forms an angle of 0 degree and the filament insertion port forms an angle of 0 to 30 degrees with respect to the port bottom surface in a direction opposite to the drug solution injection port.
【請求項5】 薬液注入口においては穿刺部径が10〜
13mmで封止する弾性体の厚みが5±2mmであり、フィ
ラメント挿入口においては穿刺部径が5〜8mmで封止す
る弾性体の厚みが7±2mmである請求項1〜4記載のい
ずれかの薬液注入ポート。
5. The puncture part diameter at the drug solution inlet is 10 to 10.
The elastic body to be sealed at 13 mm has a thickness of 5 ± 2 mm, the diameter of the puncture portion at the filament insertion opening is 5 to 8 mm, and the thickness of the elastic body to be sealed is 7 ± 2 mm. The chemical injection port.
JP10170823A 1998-06-18 1998-06-18 Medical liquid injection port Pending JP2000005322A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10170823A JP2000005322A (en) 1998-06-18 1998-06-18 Medical liquid injection port

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10170823A JP2000005322A (en) 1998-06-18 1998-06-18 Medical liquid injection port

Publications (1)

Publication Number Publication Date
JP2000005322A true JP2000005322A (en) 2000-01-11

Family

ID=15912001

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10170823A Pending JP2000005322A (en) 1998-06-18 1998-06-18 Medical liquid injection port

Country Status (1)

Country Link
JP (1) JP2000005322A (en)

Similar Documents

Publication Publication Date Title
US6290677B1 (en) Medicinal liquid injection port
EP0551017B1 (en) Implantable infusion device
US6929631B1 (en) Method and apparatus for percutaneously accessing a pressure activated implanted port
EP0746381B1 (en) Implantable access devices
US9402975B2 (en) Systems and methods to increase rigidity and snag-resistance of catheter tip
US8864724B2 (en) Catheter with valve
JP3682900B2 (en) Chemical injection port
JPH07114814B2 (en) Assembly of catheter and introducing member
JPH10127777A (en) Pharmaceutical liquid injecting port
JP4295667B2 (en) Chemical injection catheter
US11446467B2 (en) Overmolded septum for catheter hub
JP3685509B2 (en) Cap for subcutaneous implantable liquid injection port sleeve
JP2000005322A (en) Medical liquid injection port
JP2002535093A (en) Method and apparatus for percutaneous access to a pressure-operated implantation port
JP3137360B2 (en) Chemical injection port
JP3169547B2 (en) Chemical injection port
JP3447215B2 (en) Chemical injection port
JP3248839B2 (en) Chemical injection port
CN216986002U (en) Vascular access device
JPH1147278A (en) Medicinal liquid injection port
US6468252B1 (en) Clamp for vascular access device
JP2880237B2 (en) Chemical injection port
JPH11155958A (en) Medicinal liquid injecting port
CN113423446A (en) Indwelling needle for subcutaneous administration
JPH0323869A (en) Embedding type medical fluid injection port

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20050602

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050610

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050808

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20051122